Investigation of the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Opemalirsen (AZD2373)
Clinical trial NCT07154901 · COMPLETED
Trial details
- NCT number
- NCT07154901
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-18
- Primary completion
- 2026-06-15
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.